Newronika S.p.A. is a biotechnology and healthcare startup based in Italy, founded in 2008. The company's slogan "Building Brain Computers" reflects its core mission of restoring brain and body functions with innovative technologies. Newronika translates its deep knowledge of biosignal decoding into clinical practice to improve treatments, health, and wellness.
As a spin-off company of two leading research institutions in Italy, namely the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika has a strong foundation. The company's multidisciplinary team comprises experts in neuroscience, neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Newronika's revolutionary brain devices deliver the right stimulation at the right moment, enabling patients to perform normal daily activities and improve their quality of life. Recently, the company secured a significant €2.50M grant investment from The European Innovation Council on 19 December 2022.
The company's unique focus on leveraging advanced technologies to enhance brain and body functions, coupled with its strong backing from reputable research institutions, positions Newronika S.p.A. as an intriguing prospect for further investment and potential breakthroughs in the biotechnology and healthcare industries.